Projects per year
Personal profile
Headline
Fingerprint
- 1 Similar Profiles
Network
-
Molecular and Cellular Basis of the Gut-Brain Axis in Parkinsons Disease
Yue, Z. Z., Han, W., Peter, I., Peter, I., Saunders-pullman, R. R., Saunders-Pullman, R., Han, W. W. & Yue, Z.
National Institute of Neurological Disorders and Stroke
15/09/21 → 31/08/23
Project: Research
-
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
Saunders-Pullman, R. & Ozelius, L. J.
National Institute of Neurological Disorders and Stroke
1/05/19 → 31/03/22
Project: Research
-
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease
Krainc, D., Saunders-Pullman, R. & Saunders-Pullman, R.
National Institute of Neurological Disorders and Stroke
1/09/15 → 31/08/18
Project: Research
-
Phenotypic Spectrum of LRRK2 Mutations
National Institute of Neurological Disorders and Stroke
1/04/11 → 31/03/16
Project: Research
-
Gender and Hormonal Differences in Parkinson's Disease
National Institute of Neurological Disorders and Stroke
1/09/04 → 31/08/10
Project: Research
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
the MJFF Global Genetic Parkinson's Disease Study Group, Feb 2023, In: Movement Disorders. 38, 2, p. 286-303 18 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Assessment of Glucocerebrosidase Enzyme Activity in Parkinson Disease Using Multiple Approaches
Ortega, R. A., Bodamer, O., Peake, R. W. A., Raymond, D., Bressman, S. B. & Saunders-Pullman, R., Mar 2022, In: Movement Disorders. 37, 3, p. 655-656 2 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations -
Association of Olfactory Performance with Motor Decline and Age at Onset in People with Parkinson Disease and the LRRK2 G2019S Variant
Saunders-Pullman, R., Ortega, R. A., Wang, C., Raymond, D., Elango, S., Leaver, K., Urval, N., Katsnelson, V., Gerber, R., Swan, M., Shanker, V., Alcalay, R. N., Mirelman, A., Brumm, M. C., Mejia-Santana, H., Coffey, C. S., Marek, K., Ozelius, L. J., Giladi, N., Marder, K. S., & 1 others , 23 Aug 2022, In: Neurology. 99, 8, p. E814-E823Research output: Contribution to journal › Article › peer-review
-
BATL: Bayesian annotations for targeted lipidomics
Chitpin, J. G., Surendra, A., Nguyen, T. T., Taylor, G. P., Xu, H., Alecu, I., Ortega, R., Tomlinson, J. J., Crawley, A. M., McGuinty, M., Schlossmacher, M. G., Saunders-Pullman, R., Cuperlovic-Culf, M., Bennett, S. A. L. & Perkins, T. J., 15 Mar 2022, In: Bioinformatics. 38, 6, p. 1593-1599 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
Leaver, K., Viser, A., Kopell, B. H., Ortega, R. A., Miravite, J., Okun, M. S., Elango, S., Raymond, D., Bressman, S. B., Saunders-Pullman, R. & Luciano, M. S., Jul 2022, In: Journal of Neurosurgery. 137, 1, p. 184-191 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Press/Media
-
RESEARCH COMMUNITY THANKS PARKINSON'S STUDY PARTICIPANTS
Rachel Saunders-Pullman & Susan Bressman
4/11/19
1 item of Media coverage
Press/Media
-
Dial In to the Cutting-edge Neuroscience at ANA2019 during the October 15 Media Roundtable
10/10/19 → 11/10/19
2 items of Media coverage
Press/Media
-
In Small Study, Parkinson's Disease Patients with LRRK2 Mutation Have Elevated Risk for Different ...
26/09/19
1 item of Media coverage
Press/Media
-
No Harm in Using Levodopa Early in Parkinson's for Symptom Relief, but the Drug Does Not ...
Rachel Saunders-Pullman, Susan Bressman & Melissa Nirenberg
7/03/19
1 item of Media coverage
Press/Media
-
Early levodopa treatment not justified in Parkinson's disease
31/01/19
1 item of Media coverage
Press/Media